Your browser doesn't support javascript.
loading
Hitting the target in HER2 mutant cancers.
Katayama, Ryohei.
Affiliation
  • Katayama R; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan. ryohei.katayama@jfcr.or.jp.
Nat Cancer ; 3(7): 785-786, 2022 07.
Article in En | MEDLINE | ID: mdl-35883002
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Nat Cancer Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Nat Cancer Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido